PhoreMost Ltd logo

PhoreMost Ltd

PhoreMost has developed a next-generation phenotypic screening platform called 'SITESEEKER' to identify the best new targets for future therapy, and crucially, how to drug them. This has the potential to significantly increase the diversity of novel therapeutics for cancer and other unmet diseases, where treatment options are currently severely limited.

0
Management
0
Technology
0
Deals/Partnering
0
Research Pipeline
0
Funding
BioStartup's Score 0 / 50

KEY DETAILS

Websitehttps://www.phoremost.com
Founded2015
Disease Focus
Development Stage
STOCK CODENon Listed
Address
PhoreMost Ltd Building B580, Room 2011 Babraham Research Campus Babraham CB22 3AT
Cambridge
United Kingdom
Email
Contact Number

[atom_linkedin linkedin_option=”CompanyInsider” linkedin_id=”https://www.linkedin.com/company/phoremost-limited” connections=”true” suffix=””]